Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways.
Mammary gland homeostasis and the lactation-to-involution switch are regulated by serotonin (5-hydroxytryptamine (5-HT)). Mammary epithelial tight junctions are physiological targets of 5-HT, and their disruption marks an early stage of mammary gland involution. In these studies, we have identified signal transduction mechanism employed by 5-HT during regulation of mammary gland transepithelial resistance. Transepithelial electrical resistance and tight junction protein architecture were studied in cultures of MCF10A human mammary epithelial cells. Serotonin had biphasic effects on mammary epithelial resistance. At lower concentrations and earlier time points, 5-HT potentiated epithelial transmembrane resistance, whereas at higher concentrations and later time points, 5-HT decreased transepithelial electrical resistance and disrupted tight junctions. Both the early and delayed actions of 5-HT were mediated by the 5-HT7 receptor through activation of G(s)/cAMP. 5-HT induced the activities of both protein kinase A and p38 mitogen-activated protein kinase. Inhibition of p38 mitogen-activated protein kinase abrogated 5-HT-induced disruption of mammary epithelial tight junctions (the delayed effect). In contrast, inhibition of protein kinase A prevented the increased epithelial resistance in response to 5-HT (the transient effect). These studies imply an integrated set of mechanisms whereby transient, modest activation of 5-HT7 promotes tight junction integrity, and sustained 5-HT7 activation drives involution by disrupting tight junctions.
Pai
Vaibhav P
VP
Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio 45267-0576, USA.
Horseman
Nelson D
ND
D045744:Cell Line, Tumor; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D017097:Electric Impedance; D005260:Female; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects* / Q000502:physiology; D042361:Mammary Glands, Human / Q000166:cytology / Q000378:metabolism*; D011985:Receptors, Serotonin / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology*; D019108:Tight Junctions / Q000378:metabolism*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
D011985:Receptors, Serotonin; C104425:serotonin 7 receptor; D012701:Serotonin; D017868:Cyclic AMP-Dependent Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases
J Cell Biol. 2000 Nov 27;151(5):F31-6
11086016
J Cell Physiol. 2005 Jun;203(3):564-72
15605377
Acta Endocrinol (Copenh). 1960 Jan;33:73-80
13835391
Annu Rev Cell Dev Biol. 2006;22:207-35
16771626
Am J Physiol. 1995 Oct;269(4 Pt 2):R848-55
7485602
J Biol Chem. 2001 Oct 19;276(42):38480-6
11502742
J Biol Chem. 1994 Jun 10;269(23):16108-15
8206910
J Pharmacol Exp Ther. 2005 Jun;313(3):1003-10
15716386
J Biol Chem. 1994 Mar 18;269(11):7851-4
8132501
Cell Signal. 1996 Jun;8(4):235-45
8842523
J Biol Chem. 2004 Apr 23;279(17):17366-75
14970210
J Mammary Gland Biol Neoplasia. 1998 Jul;3(3):233-46
10819511
Mol Endocrinol. 2002 Dec;16(12):2675-91
12456789
J Endocrinol. 2001 Aug;170(2):347-56
11479131
J Cell Biol. 1997 Jun 16;137(6):1393-401
9182670
Br J Pharmacol. 2004 Oct;143(3):404-10
15339860
Biochim Biophys Acta. 2008 Mar;1778(3):601-13
18339298
Proc Soc Exp Biol Med. 1959 Aug-Sep;101:699-703
13829719
J Cell Sci. 1993 Oct;106 ( Pt 2):641-8
8282768
J Biol Chem. 2005 Jul 15;280(28):26233-40
15905176
Zentralbl Gynakol. 1972 Dec 9;94(49):1081-6
4650317
Br J Pharmacol. 2002 Mar;135(6):1563-71
11906971
Biochim Biophys Acta. 2008 Mar;1778(3):729-56
17950242
Cell. 2002 Oct 4;111(1):29-40
12372298
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8547-51
8397408
Mol Cell Endocrinol. 1999 Oct 25;156(1-2):55-61
10612423
Am J Physiol. 1997 Jul;273(1 Pt 2):R379-86
9249575
J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):25-35
17431797
Methods. 2003 Jul;30(3):256-68
12798140
Breast Cancer Res. 2006;8(2):203
16677411
J Dairy Res. 1982 Feb;49(1):1-11
7076943
J Dairy Sci. 2008 May;91(5):1834-44
18420614
Adv Drug Deliv Rev. 2003 Apr 29;55(5):629-41
12706546
Cancer Res. 1990 Sep 15;50(18):6075-86
1975513
J Mol Endocrinol. 1998 Oct;21(2):169-77
9801460
J Dairy Sci. 1994 Feb;77(2):426-32
8182166
J Neurochem. 2003 Dec;87(5):1076-85
14622088
Rev Reprod. 1998 May;3(2):104-12
9685189
J Biol Chem. 2002 Jul 5;277(27):24197-203
11978790
Endocrinology. 1969 Jul;85(1):155-60
4306740
Am J Physiol. 1984 Jul;247(1 Pt 1):C20-5
6742181
Development. 1996 Jan;122(1):181-93
8565829
Brain Res. 1998 Feb 16;784(1-2):57-62
9518551
Endocrinology. 1994 Sep;135(3):1119-24
8070355
J Neurosci. 2005 Aug 24;25(34):7821-30
16120784
Pharmacol Ther. 2001 Nov-Dec;92(2-3):179-212
11916537
Am J Physiol Cell Physiol. 2004 Jun;286(6):C1213-28
15151915
Eur J Cancer. 2004 Dec;40(18):2717-25
15571953
Biochem J. 1987 Feb 15;242(1):285-8
3593242
J Biol Chem. 1993 Nov 5;268(31):23422-6
8226867
Dev Cell. 2004 Feb;6(2):193-203
14960274
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16708-13
17940054
J Physiol. 1980 Apr;301:415-28
7411441
Exp Cell Res. 2007 May 1;313(8):1533-47
17374535